Start Date
January 30, 2024
Primary Completion Date
December 30, 2024
Study Completion Date
December 30, 2024
No Intervention
As this is an observational study, no intervention will be administered in this study.
Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College, Beijing
Lead Sponsor
Takeda
INDUSTRY